Analysis of Bioactive Compounds in Indigenous Mushrooms for Neurodegenerative Treatments

Antiphospholipid antibody syndrome (APS) is an autoimmune disorder characterized by the persistently elevated levels of antiphospholipid antibodies (aPL) and is associated with recurrent thromboembolic events and complications in pregnancy. To diagnose definite APS, the classification criteria require at least one clinical criterion (either thrombosis or pregnancy complications) to be present, along with one laboratory criterion, which includes the presence of lupus anticoagulant (LAC), anticardiolipin (a CL) antibodies, or anti-β2-glycoprotein I (aβ2GPI) antibodies on two or more separate occasions, at least 12 weeks apart. Additionally, thrombosis must be confirmed using objective, validated diagnostic methods. In this report, a patient of 27-year-old female with multiple headache attacks and thrombotic events, was evaluated for APS secondary to stroke. The patient was managed with anticoagulation therapy and remained clinically stable following intervention.